HMOX1 and prostate carcinoma: In A549 lung cancer cells and DU145 prostate cancer cells that overexpression of HO-1 and SPP, knockdown of the SPP genes using siRNA or pharmacologic inhibition of SPP significantly reduced nuclear localization of HO-1 (Hsu et al., 2015).